| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |